Aptevo Therapeutics (NASDAQ:APVO) Coverage Initiated by Analysts at StockNews.com

StockNews.com began coverage on shares of Aptevo Therapeutics (NASDAQ:APVO – Free Report) in a report released on Monday. The brokerage issued a hold rating on the biotechnology company’s stock. Separately, Alliance Global Partners began coverage on shares of Aptevo Therapeutics in a research report on Monday, October 9th. They set a buy rating on the […]

Leave a Reply

Your email address will not be published.

Previous post Bilibili (NASDAQ:BILI) Stock Rating Lowered by UBS Group
Next post Anheuser-Busch InBev SA/NV (NYSE:BUD) Downgraded by Deutsche Bank Aktiengesellschaft